Corcept CBO reports 600-share stock gift
Corcept Therapeutics Chief Business Officer Gary Charles Robb reported a Form 4 showing a bona fide gift of 600 shares of Corcept Therapeutics common stock on May 27, 2026.
Rhea-AI Filing Summary
Corcept Therapeutics Chief Business Officer Gary Charles Robb reported a Form 4 showing a bona fide gift of 600 shares of Corcept Therapeutics common stock on May 27, 2026. The gift carried no sale price. After this transfer, he directly holds 25,081 shares of common stock. He also indirectly holds shares through a revocable trust with 49,716 shares and through two custodial accounts for children, each with 12,571 shares. Footnotes note additional unvested restricted stock awards scheduled to vest on the one-year anniversaries of their respective grant dates, subject to service conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
600 shares gifted
Gift
4 txns
Insider
Robb Gary Charles
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 600 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 25,081 shares (Direct);
Common Stock — 25,142 shares (Indirect, Custodial Account for Child);
Common Stock — 49,716 shares (Indirect, Gary Charles Robb TTE Robb Revocable Trust)
Footnotes (4)
- F1. Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F2. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F3. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F4. These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
Key Figures
Gifted shares: 600 shares
Gift price: $0.00 per share
Direct holdings after gift: 25,081 shares
+5 more
8 metrics
Gifted shares
600 shares
Bona fide gift of common stock on May 27, 2026
Gift price
$0.00 per share
Stated transaction price for gifted shares
Direct holdings after gift
25,081 shares
Common stock directly held following the transaction
Trust holdings
49,716 shares
Common stock held by Robb Revocable Trust
Custodial account holdings
12,571 shares each
Common stock in each custodial account for a child
Unvested RSU grant 1
251 shares
Restricted stock award granted September 2, 2025
Unvested RSU grant 2
224 shares
Restricted stock award granted December 1, 2025
Unvested RSU grant 3
499 shares
Restricted stock award granted March 2, 2026
Key Terms
bona fide gift, restricted stock awards, Uniform Transfers to Minors Act, revocable trust
4 terms
bona fide gift financial
"transaction_code_description": "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
restricted stock awards financial
"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Uniform Transfers to Minors Act financial
"custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian"
revocable trust financial
"held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Corcept Therapeutics (CORT) report for Gary Charles Robb?
Corcept Therapeutics reported that Chief Business Officer Gary Charles Robb made a bona fide gift of 600 shares of common stock. The transaction was recorded at a price of $0.00 per share and classified as a non-sale disposition.
What indirect Corcept Therapeutics (CORT) holdings are associated with Gary Charles Robb?
Indirectly, shares are held through a revocable trust and custodial accounts for his children. The revocable trust holds 49,716 shares, and each custodial account under the Uniform Transfers to Minors Act holds 12,571 shares of Corcept Therapeutics common stock.
Was the Corcept Therapeutics (CORT) insider transaction a sale or a gift?
The filing classifies the transaction as a bona fide gift, not a sale. It is coded as “G” on Form 4, with 600 shares transferred at a stated price of $0.00 per share, indicating no sale proceeds were received.
What restricted stock awards are outstanding for Gary Charles Robb at Corcept Therapeutics (CORT)?
Footnotes state he has unvested restricted stock awards for 251, 224, 499, and 776 shares from grants on September 2, 2025, December 1, 2025, March 2, 2026, and June 1, 2026. Each award vests fully one year after its grant date, subject to requirements.
Does the Corcept Therapeutics (CORT) Form 4 show any open-market buying or selling by Gary Charles Robb?
The Form 4 does not show open-market purchases or sales by Gary Charles Robb. It reports a bona fide gift disposition of 600 shares and multiple holding entries related to his direct, trust, and custodial account positions in Corcept Therapeutics stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
